Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.

NCT00154401 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00154401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00154401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
October 31, 2005
Enrollment
177 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2